These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12373504)

  • 1. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.
    Nuesch R; Geigy N; Schaedler E; Battegay M
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):684-7. PubMed ID: 12373504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
    Fox R; Gourlay YJ
    Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment (1995-2003) of hospitalizations of HIV-infected patients within a geographical population in Canada.
    Krentz HB; Dean S; Gill MJ
    HIV Med; 2006 Oct; 7(7):457-66. PubMed ID: 16925732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV patient hospitalization during the pre and post-HAART era].
    Pérez E; Toibaro JJ; Losso MH
    Medicina (B Aires); 2005; 65(6):482-8. PubMed ID: 16433473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
    J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.
    Wyatt CM; Arons RR; Klotman PE; Klotman ME
    AIDS; 2006 Feb; 20(4):561-5. PubMed ID: 16470120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral medication errors among hospitalized patients with HIV infection.
    Rastegar DA; Knight AM; Monolakis JS
    Clin Infect Dis; 2006 Oct; 43(7):933-8. PubMed ID: 16941379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected population.
    Lohse N; Ladefoged K; Pedersen L; Jensen-Fangel S; Sørensen HT; Obel N
    Scand J Infect Dis; 2004; 36(10):738-42. PubMed ID: 15513400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
    Martín-Carbonero L; Sánchez-Somolinos M; García-Samaniego J; Núñez MJ; Valencia ME; González-Lahoz J; Soriano V
    J Viral Hepat; 2006 Dec; 13(12):851-7. PubMed ID: 17109686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination.
    Klein MB; Lu Y; DelBalso L; Coté S; Boivin G
    Clin Infect Dis; 2007 Jul; 45(2):234-40. PubMed ID: 17578785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.